Vollum Institute, Oregon Health Sciences University, Portland, Oregon, USA.
Pharmacol Rev. 2013 Jan 15;65(1):223-54. doi: 10.1124/pr.112.005942. Print 2013 Jan.
Morphine and related µ-opioid receptor (MOR) agonists remain among the most effective drugs known for acute relief of severe pain. A major problem in treating painful conditions is that tolerance limits the long-term utility of opioid agonists. Considerable effort has been expended on developing an understanding of the molecular and cellular processes that underlie acute MOR signaling, short-term receptor regulation, and the progression of events that lead to tolerance for different MOR agonists. Although great progress has been made in the past decade, many points of contention and controversy cloud the realization of this progress. This review attempts to clarify some confusion by clearly defining terms, such as desensitization and tolerance, and addressing optimal pharmacological analyses for discerning relative importance of these cellular mechanisms. Cellular and molecular mechanisms regulating MOR function by phosphorylation relative to receptor desensitization and endocytosis are comprehensively reviewed, with an emphasis on agonist-biased regulation and areas where knowledge is lacking or controversial. The implications of these mechanisms for understanding the substantial contribution of MOR signaling to opioid tolerance are then considered in detail. While some functional MOR regulatory mechanisms contributing to tolerance are clearly understood, there are large gaps in understanding the molecular processes responsible for loss of MOR function after chronic exposure to opioids. Further elucidation of the cellular mechanisms that are regulated by opioids will be necessary for the successful development of MOR-based approaches to new pain therapeutics that limit the development of tolerance.
吗啡和相关的μ-阿片受体(MOR)激动剂仍然是治疗严重疼痛的最有效药物之一。在治疗疼痛病症时,一个主要问题是耐受限制了阿片类激动剂的长期效用。人们已经付出了大量努力来了解导致急性 MOR 信号转导、短期受体调节以及导致不同 MOR 激动剂耐受的事件进展的分子和细胞过程。尽管在过去十年中取得了很大进展,但许多争议和争议点使这一进展的实现蒙上了阴影。本综述试图通过明确界定术语(如脱敏和耐受)来澄清一些混淆,并解决区分这些细胞机制相对重要性的最佳药理学分析,从而澄清一些混淆。全面综述了磷酸化相对于受体脱敏和内吞作用调节 MOR 功能的细胞和分子机制,并强调了激动剂偏向调节以及知识缺乏或存在争议的领域。然后详细考虑了这些机制对理解 MOR 信号转导对阿片耐受的重要贡献的意义。虽然一些导致耐受的功能性 MOR 调节机制已经清楚,但对于慢性暴露于阿片类药物后导致 MOR 功能丧失的分子过程仍存在很大的理解差距。进一步阐明受阿片类药物调节的细胞机制对于成功开发基于 MOR 的新疼痛治疗方法以限制耐受的发展是必要的。